Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Wolfe Research Downgrades AbbVie to Peer Perform

Wolfe Research Downgrades AbbVie to Peer Perform

Wolfe Research analyst Tim Anderson downgrades AbbVie (NYSE:ABBV) from Outperform to Peer Perform.

byBenzinga Newsdesk

February 22, 2023

1 minute read

Wolfe Research analyst Tim Anderson downgrades AbbVie (NYSE:ABBV) from Outperform to Peer Perform.

Analyst Ratings

Unveiling 13 Analyst Insights On Neurocrine Biosciences

By Benzinga Insights

January 23, 11:00 AM

Across the recent three months, 13 analysts have shared their insights on Neurocrine Biosciences (NASDAQ:NBIX), expressing a variety…

NBIX

Bitcoin Spot ETFs Can’t Get Enough With Historic 18-Day Buying Spree: Is This A New Gold Rush?

By Aniket Verma

June 7, 4:21 AM

In a telling reflection of growing institutional demand for cryptocurrencies, Bitcoin (CRYPTO: BTC) spot exchange-traded funds in the U.S. attracted net inflows for a record-breaking 18th day.

BTC

MongoDB Q3 Performance Highlights: EPS Beat, Revenue Up 30%, Strong Guidance And More

By Adam Eckert

December 5, 5:19 PM

MongoDB Inc (NYSE: MDB) reported third-quarter financial results after the close on Tuesday.

MDB

Analyst Ratings

4 Analysts Have This to Say About General Dynamics

By Benzinga Insights

March 30, 5:01 PM

General Dynamics (NYSE:GD) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

Wolfe Research Downgrades AbbVie to Peer Perform

Related Posts

Unveiling 13 Analyst Insights On Neurocrine Biosciences

Bitcoin Spot ETFs Can’t Get Enough With Historic 18-Day Buying Spree: Is This A New Gold Rush?

MongoDB Q3 Performance Highlights: EPS Beat, Revenue Up 30%, Strong Guidance And More

4 Analysts Have This to Say About General Dynamics